Nektar Therapeutics (NKTR): Capital Expenditures
$171.0K
Year ended 2025-12-31
$244.0K
Trailing 12 months to 2026-06-30
-68.9%
3-year compound annual growth
-52.7%
5-year compound annual growth
-34.2%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $171.0K | -88.4% | 2026-03-13, From 2025-01-01 |
| 2024-12-31 | $1.47M | +69.7% | 2026-03-13, From 2024-01-01 |
| 2023-12-31 | $865.0K | -84.8% | 2025-03-14, From 2023-01-01 |
| 2022-12-31 | $5.68M | -62.1% | 2024-03-05, From 2022-01-01 |
| 2021-12-31 | $14.99M | +106.5% | 2024-03-05, From 2021-01-01 |
| 2020-12-31 | $7.26M | -72.4% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $26.29M | +84.6% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $14.24M | +47.2% | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | $9.68M | +51.4% | 2020-02-28, From 2017-01-01 |
| 2016-12-31 | $6.39M | -42.9% | 2019-03-01, From 2016-01-01 |
| 2015-12-31 | $11.20M | +12.2% | 2018-03-01, From 2015-01-01 |
| 2014-12-31 | $9.98M | +143.9% | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | $4.09M | -61.3% | 2016-02-29, From 2013-01-01 |
| 2012-12-31 | $10.58M | +8.9% | 2015-02-26, From 2012-01-01 |
| 2011-12-31 | $9.72M | -69.1% | 2014-02-27, From 2011-01-01 |
| 2010-12-31 | $31.46M | +91.9% | 2013-03-01, From 2010-01-01 |
| 2009-12-31 | $16.39M | n/a | 2012-02-29, From 2009-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Nektar Therapeutics (NKTR) | 2025-12-31 | $171.0K | -88.4% |
| Agios Pharmaceuticals, Inc. (AGIO) | 2025-12-31 | $4.32M | +156.1% |
| Q32 Bio Inc. (QTTB) | 2025-12-31 | $0 | -100.0% |
| Aytu Biopharma, Inc (AYTU) | 2026-06-30 | $29.0K | -87.3% |
| Ocular Therapeutix, Inc (OCUL) | 2025-12-31 | $12.01M | +832.5% |
| Journey Medical Corp (DERM) | 2024-12-31 | $15.00M | +200.0% |
| Lexicon Pharmaceuticals, Inc. (LXRX) | 2025-12-31 | $0 | -100.0% |
| Tango Therapeutics, Inc. (TNGX) | 2025-12-31 | $1.05M | +39.0% |
| Gossamer Bio, Inc. (GOSS) | 2025-12-31 | $79.0K | n/a |
Compare NKTR, AGIO, QTTB, AYTU side by side · Screen every company in Pharmaceutical Preparations ↗